Prothena (PRTA) Stock Highlights

21.48 | -2.1%

2024-09-19 03:12:59

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The companys clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinsons disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Statistics

Range Today

20.96 22.41

Volume Today 586.5K

Range 1 Year

18.69 55.89

Volume 1 Year 158.86M

Range 3 Year

18.69 79.75

Volume 3 Year 397.06M

Range 10 Year

6.71 79.75

Volume 10 Year 1.09B

Highlights

Market Capitalization 1.19B (small)

Floating Shares 38.35M

Current Price 21.48

Price To Earnings -22.41

Price To Revenue 2.93

Price To Book 2.04

Earnings Per Share -0.94

Payout Ratio 0%

Performance

Latest -2.1%

1 Month +2.78%

3 Months +5.09%

6 Months -17.1%

1 Year -58.58%

3 Years -71.44%

5 Years +147.47%

10 Years -9.44%

Benchmarks

Market Capitalization

94 / 368

Gross Profits

227 / 278

Total Revenue

78 / 300

Total Rank

348 / 368

Free Cashflow

95 / 352

Performance 5 years

57 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.